A machine learning prediction model and online calculator for postoperative recurrence of secondary hyperparathyroidism: A dual-center development and validation study
- Journal
- International journal of medical informatics (Q1)
- Published
- 10 September 2026
- Study design
- Unclassified
- Evidence level
- Level 5, Expert Opinion (CEBM 5)
- Authors
- Runmin Cao, Yurun Zhang, Ling Cao, Honghe Jiang
- PMID
- 42731361
- DOI
- 10.1016/j.ijmedinf.2026.106718
Why clinicians should know about it
- Picked for Health Informatics (paper of the day, 15 September 2026): Online calculator predicts postoperative SHPT recurrence
Abstract
BACKGROUND: Secondary hyperparathyroidism carries a high recurrence risk after parathyroidectomy (PTX), requiring early identification of high-risk patients. Using a two-center cohort, we developed a machine learning prediction model and deployed it as an online calculator. METHODS: We included 391 SHPT patients undergoing PTX at two hospitals. Cohort 1 was split 7:3 into training and internal validation sets; cohort 2 served as external validation. Feature selection used LASSO and Boruta, SMOTE handled imbalance, and six models (random forest, XGBoost, etc.) were built. After cross-validation and grid search, the best model was chosen by AUC and F1, interpreted with SHAP, and deployed online. RESULTS: Six predictors were identified: preoperative phosphorus, bone pain score, surgical method, total parathyroid volume, and iPTH at postoperative months 1 and 3. The random forest model performed best (internal validation AUC 0.890). External validation showed AUC 0.889. Early postoperative iPTH was the most important predictor.Online calculator to get the address: https://lhssniegkalmhjphs9exbz.streamlit.app/. CONCLUSION: We developed and dual-center validated a robust SHPT recurrence prediction model. The online calculator enables convenient individualized risk assessment, optimizing postoperative monitoring.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.